Area of research
Cancer Research · Oncology
Research interest
Research focused on Pancreatic cancer and SMARCA4, with related work in Lymphoplasmacytic Lymphoma, Vorinostat, Epigenomics. Notable publications include 'Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients', 'Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4', and 'Response Rate Following Albumin-Bound Paclitaxel Plus Gemcitabine Plus Cisplatin Treatment Among Patients With Advanced Pancreatic Cancer'.
Pembrolizumab ± paricalcitol in metastatic pancreatic cancer postmaximal cytoreduction
A super-enhancer-regulated RNA-binding protein cascade drives pancreatic cancer
Genomic and Epigenomic Landscaping Defines New Therapeutic Targets for Adenosquamous Carcinoma of the Pancreas
Response Rate Following Albumin-Bound Paclitaxel Plus Gemcitabine Plus Cisplatin Treatment Among Patients With Advanced Pancreatic Cancer
A phase 2 study of vorinostat in locally advanced, recurrent, or metastatic adenoid cystic carcinoma
Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients
Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4
STAG2 is a clinically relevant tumor suppressor in pancreatic ductal adenocarcinoma
Genomic analysis of marginal zone and lymphoplasmacytic lymphomas identified common and disease-specific abnormalities